3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Renal cell carcinoma (RCC), a prevalent form of renal malignancy, is distinguished by its proclivity for robust tumor proliferation and metastatic dissemination. Long non-coding RNAs (lncRNAs) have emerged as pivotal modulators of gene expression, exerting substantial influence over diverse biological processes, encompassing the intricate landscape of cancer development. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1), an exemplar among lncRNAs, has been discovered to assume functional responsibilities within the context of RCC. The conspicuous expression of MALAT-1 in RCC cells has been closely linked to the advancement of tumors and an unfavorable prognosis. Experimental evidence has demonstrated the pronounced ability of MALAT-1 to stimulate RCC cell proliferation, migration, and invasion, thereby underscoring its active participation in facilitating the metastatic cascade. Furthermore, MALAT-1 has been implicated in orchestrating angiogenesis, an indispensable process for tumor expansion and metastatic dissemination, through its regulatory influence on pro-angiogenic factor expression. MALAT-1 has also been linked to the evasion of immune surveillance in RCC, as it can regulate the expression of immune checkpoint molecules and modulate the tumor microenvironment. Hence, the potential utility of MALAT-1 as a diagnostic and prognostic biomarker in RCC emerges, warranting further investigation and validation of its clinical significance. This comprehensive review provides an overview of the diverse functional roles exhibited by MALAT-1 in RCC.

          Related collections

          Most cited references69

          • Record: found
          • Abstract: not found
          • Article: not found

          The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The long noncoding RNA Malat1: Its physiological and pathophysiological functions.

            Recent studies suggest that in humans, DNA sequences responsible for protein coding regions comprise only 2% of the total genome. The rest of the transcripts result in RNA transcripts without protein-coding ability, including long noncoding RNAs (lncRNAs). Different from most members in the lncRNA family, the metastasis-associated lung adenocarcinoma transcript 1 (Malat1) is abundantly expressed and evolutionarily conserved throughout various mammalian species. Malat1 is one of the first identified lncRNAs associated with human disease, and cumulative studies have indicated that Malat1 plays critical roles in the development and progression of various cancers. Malat1 is also actively involved in various physiologic processes, including alternative splicing, epigenetic modification of gene expression, synapse formation, and myogenesis. Furthermore, extensive evidences show that Malat1 plays pivotal roles in multiple pathological conditions as well. In this review, we will summarize latest findings related to the physiologic and pathophysiological processes of Malat1 and discuss its therapeutic potentials.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma

              Renal cell carcinoma stands out as one of the most immune infiltrated tumors in pan-cancer comparisons. Features of the tumor microenvironment heavily impact disease biology and may affect responses to systemic therapy. With evolving frontline options in the metastatic setting, several immune checkpoint blockade regimens have emerged as efficacious, and there is growing interest in characterizing features of tumor biology that can reproducibly prognosticate patients and/or predict the likelihood of deriving therapeutic benefit. Herein, we review pertinent characteristics of the tumor microenvironment with dedicated attention to candidate prognostic and predictive signatures as well as possible targets for future drug development.
                Bookmark

                Author and article information

                Contributors
                Maryamfarzaneh2013@yahoo.com
                obm3@pitt.edu
                Journal
                BMC Nephrol
                BMC Nephrol
                BMC Nephrology
                BioMed Central (London )
                1471-2369
                20 December 2023
                20 December 2023
                2023
                : 24
                : 380
                Affiliations
                [1 ]GRID grid.412571.4, ISNI 0000 0000 8819 4698, Cardiovascular Research Center, School of Medicine, , Namazi Hospital, Shiraz University of Medical Sciences, ; Shiraz, Iran
                [2 ]Faculty of Medicine, Dezful University of Medical Sciences, ( https://ror.org/033hgcp80) Dezful, Iran
                [3 ]Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, ( https://ror.org/04waqzz56) Isfahan, Iran
                [4 ]Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, ( https://ror.org/01rws6r75) Ahvaz, Iran
                [5 ]Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, ( https://ror.org/01rws6r75) Ahvaz, Iran
                [6 ]Department of Human Morphology and Embryology Division of Anatomy, Wrocław Medical University, ( https://ror.org/01qpw1b93) Wrocław, Poland
                [7 ]Department of Veterinary Surgery, Institute of Veterinary Medicine, Nicolaus Copernicus University, ( https://ror.org/0102mm775) Torun, Poland
                [8 ]GRID grid.40803.3f, ISNI 0000 0001 2173 6074, Physiology Graduate Faculty North, , Carolina State University, ; Raleigh, NC 27695 US
                [9 ]Center of Assisted Reproduction Department of Obstetrics and Gynecology, University Hospital and Masaryk University, ( https://ror.org/02j46qs45) Brno, Czech Republic
                [10 ]Department of Internal Medicine, School of Science, Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Science, ( https://ror.org/01rws6r75) Ahvaz, Iran
                [11 ]Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, ( https://ror.org/01rws6r75) Ahvaz, Iran
                [12 ]Division of Biological and Health Sciences, University of Pittsburgh at Bradford, ( https://ror.org/0019bf448) Bradford, PA USA
                Article
                3438
                10.1186/s12882-023-03438-1
                10731893
                38124072
                a56d1601-8bc3-429b-a47f-20d9f3295994
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 28 October 2023
                : 12 December 2023
                Categories
                Review
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2023

                Nephrology
                renal cell carcinoma,lncrnas,malat-1,biomarker
                Nephrology
                renal cell carcinoma, lncrnas, malat-1, biomarker

                Comments

                Comment on this article